Towards precision medicine for sepsis patients
Open Access
- 12 January 2017
- journal article
- editorial
- Published by Springer Nature in Critical Care
- Vol. 21 (1) , 11
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational studyCritical Care, 2016
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1Journal of Leukocyte Biology, 2016
- Monocyte programmed death ligand-1 expression after 3–4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort studyCritical Care, 2016
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation SyndromeCritical Care Medicine, 2016
- Sepsis-induced immune dysfunction: can immune therapies reduce mortality?Journal of Clinical Investigation, 2016
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer TherapyCancer Cell, 2015
- Why have clinical trials in sepsis failed?Trends in Molecular Medicine, 2014
- Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?American Journal of Respiratory and Critical Care Medicine, 2013
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Confirmatory interleukin-1 receptor antagonist trial in severe sepsisCritical Care Medicine, 1997